Literature DB >> 2429169

Measurement of bleomycin, neocarzinostatin, and auromomycin cleavage of cell-free and intracellular simian virus 40 DNA and chromatin.

J E Grimwade, T A Beerman.   

Abstract

Simian virus 40 (SV40) was used as a model for eukaryotic chromatin to allow analysis of strand scission drug action on DNA of the same nucleotide sequence in different environments. Cleavage of purified DNA, cell-free chromatin, and intracellular chromatin by the antitumor drugs bleomycin, neocarzinostatin, and auromomycin was assayed. Comparison of total (single-and double-stranded) drug-induced cutting of purified SV40 DNA and isolated viral minichromosomes, as measured by the conversion of supercoiled DNA to the nicked circular form, revealed that a 2-3-fold higher concentration of all three drugs is required to cut minichromosomes as extensively as naked DNA. In addition, differences in drug activity on cell-free nuclear viral chromatin and intracellular SV40 chromatin were measured. Three times more auromomycin was needed to cut intracellular SV40 DNA as extensively as the viral DNA in isolated nuclei, whereas, surprisingly, the increases in bleomycin and neocarzinostatin concentrations were 200-fold and 1000-fold respectively. When the drugs were used to treat SV40-infected cells, no repair of strand scissions was detected. Formation of double-stranded breaks by bleomycin, neocarzinostatin, and automomycin, measured at equivalent levels of total cleavage, was also examined to provide information on the distribution of strand scissions in different environments. Nucleoproteins were found to cause a 3-fold higher level of neocarzinostatin-induced double-stranded breaks to be made on isolated minichromosomes than on purified DNA, but they had no effect on double-stranded break formation by either bleomycin or auromomycin. In contrast, auromomycin made twice as many double-stranded breaks on intracellular SV40 DNA as on minichromosomes in isolated nuclei. However, neither bleomycin- nor neocarzinostatin-induced double-stranded breaks on intracellular SV40 DNA were significantly different from those made on SV40 in isolated nuclei.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429169

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  7 in total

1.  The radiomimetic enediyne C-1027 induces unusual DNA damage responses to double-strand breaks.

Authors:  Daniel R Kennedy; Terry A Beerman
Journal:  Biochemistry       Date:  2006-03-21       Impact factor: 3.162

2.  Site specificity of bleomycin cleavage in purified and intracellular simian virus 40 DNA.

Authors:  J E Grimwade; E B Cason; T A Beerman
Journal:  Nucleic Acids Res       Date:  1987-08-25       Impact factor: 16.971

3.  The radiomimetic enediyne, 20'-deschloro-C-1027 induces inter-strand DNA crosslinks in hypoxic cells and overcomes cytotoxic radioresistance.

Authors:  Terry A Beerman; Loretta S Gawron; Ben Shen; Daniel R Kennedy
Journal:  DNA Repair (Amst)       Date:  2014-06-28

4.  DNA crosslinking and biological activity of a hairpin polyamide-chlorambucil conjugate.

Authors:  Yong-Dong Wang; Jaroslaw Dziegielewski; Nicholas R Wurtz; Barbara Dziegielewska; Peter B Dervan; Terry A Beerman
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

5.  Crystal structure analysis of auromomycin apoprotein (macromomycin) shows importance of protein side chains to chromophore binding selectivity.

Authors:  P Van Roey; T A Beerman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  Designer enediynes generate DNA breaks, interstrand cross-links, or both, with concomitant changes in the regulation of DNA damage responses.

Authors:  Daniel R Kennedy; Jianhua Ju; Ben Shen; Terry A Beerman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-31       Impact factor: 11.205

7.  The ratio of single- to double-strand DNA breaks and their absolute values determine cell death pathway.

Authors:  O Tounekti; A Kenani; N Foray; S Orlowski; L M Mir
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.